Polyrizon shares surge 98.73% after-hours on manufacturing milestone and superior hydrogel mucoadhesion data validating nasal spray platform.

jueves, 4 de diciembre de 2025, 5:23 pm ET1 min de lectura
PLRZ--
Polyrizon Ltd. (Nasdaq: PLRZ) surged 98.73% in after-hours trading following two pivotal developments: (1) the announcement of a successful manufacturing milestone for its flagship allergy blocker PL-14, enabling large-scale production and advancing clinical trial readiness, and (2) new preclinical data demonstrating its Trap & Target™ (T&T) naloxone hydrogel’s superior.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios